10-Q Filing

Dominari Holdings Inc. CIK: 12239 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001213900-20-020670`
Period End Date	20200630
Filing Date	20200806
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	aiki-20200630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 50 Income Statement 52 Cash Flow Statement 56 Stockholders Equity 31

Balance Sheet 50 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$564.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.83M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$857.00K	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$26.31M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$181.00K	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$105.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.13M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	34.92M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$29.25M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	4.83M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	4.83M	shares	Point-in-time
Investments	`Investments`	$3.21M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	34.92M	shares	Point-in-time
Investments	`Investments`	$10.15M	USD	Point-in-time
Treasury stock	`TreasuryStockShares`	3.00	shares	Point-in-time
Treasury stock	`TreasuryStockShares`	3.00	shares	Point-in-time
Total assets	`Assets`	$32.46M	USD	Point-in-time
Total assets	`Assets`	$11.28M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$68.00K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$676.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$293.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$682.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$750.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$969.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$969.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$750.00K	USD	Point-in-time
Preferred Stock	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 34,920,222 and 4,825,552 shares issued at June 30, 2020 and December 31, 2019, respectively; 34,920,219 and 4,825,549 shares outstanding at June 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 34,920,222 and 4,825,552 shares issued at June 30, 2020 and December 31, 2019, respectively; 34,920,219 and 4,825,549 shares outstanding at June 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	-	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$186.67M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$155.06M	USD	Point-in-time
Treasury stock, at cost, 3 shares at June 30, 2020 and December 31, 2019	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Treasury stock, at cost, 3 shares at June 30, 2020 and December 31, 2019	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-144.27M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-154.91M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.98M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.53M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$11.21M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.96M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$31.49M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$32.46M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$11.28M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`SellingGeneralAndAdministrativeExpense`	$888.00K	USD	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$1.02M	USD	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$2.32M	USD	2 Qtrs
General and administrative	`SellingGeneralAndAdministrativeExpense`	$1.60M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	-	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$760.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$675.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	-	USD	1 Quarter
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	-	USD	2 Qtrs
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$1.11M	USD	2 Qtrs
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	-	USD	1 Quarter
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$102.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$888.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.60M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.79M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.19M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.79M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-888.00K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.60M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-4.19M	USD	2 Qtrs
Other income	`OtherIncome`	-	USD	2 Qtrs
Other income	`OtherIncome`	-	USD	1 Quarter
Other income	`OtherIncome`	$15.00K	USD	2 Qtrs
Other income	`OtherIncome`	$15.00K	USD	1 Quarter
Gains and (losses) on marketable securities	`MarketableSecuritiesGainLoss`	$1.12M	USD	1 Quarter
Gains and (losses) on marketable securities	`MarketableSecuritiesGainLoss`	$64.00K	USD	2 Qtrs
Gains and (losses) on marketable securities	`MarketableSecuritiesGainLoss`	$-28.00K	USD	1 Quarter
Gains and (losses) on marketable securities	`MarketableSecuritiesGainLoss`	$262.00K	USD	2 Qtrs
Change in fair value of investment	`GainLossOnInvestments`	$145.00K	USD	1 Quarter
Change in fair value of investment	`GainLossOnInvestments`	$-6.73M	USD	2 Qtrs
Change in fair value of investment	`GainLossOnInvestments`	$-1.66M	USD	1 Quarter
Change in fair value of investment	`GainLossOnInvestments`	$-330.00K	USD	2 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-74.00K	USD	2 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-127.00K	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Total other (expenses) income	`NonoperatingIncomeExpense`	$-519.00K	USD	1 Quarter
Total other (expenses) income	`NonoperatingIncomeExpense`	$-6.45M	USD	2 Qtrs
Total other (expenses) income	`NonoperatingIncomeExpense`	$-192.00K	USD	2 Qtrs
Total other (expenses) income	`NonoperatingIncomeExpense`	$244.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.65M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-644.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.31M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.79M	USD	2 Qtrs
Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.30	USD	1 Quarter
Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.50	USD	2 Qtrs
Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.87	USD	2 Qtrs
Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.07M	shares	2 Qtrs
Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	32.98M	shares	1 Quarter
Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	21.09M	shares	2 Qtrs
Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.12M	shares	1 Quarter

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-10.65M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-644.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.31M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.79M	USD	2 Qtrs
Change in fair value of investment	`ChangeInFairValueOfInvestment`	$-6.73M	USD	2 Qtrs
Change in fair value of investment	`ChangeInFairValueOfInvestment`	$-330.00K	USD	2 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentsForWarrantLiabilities`	-	USD	2 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentsForWarrantLiabilities`	$74.00K	USD	2 Qtrs
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	-	USD	2 Qtrs
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	$1.11M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	-	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$115.00K	USD	2 Qtrs
Realized (gain) loss on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$544.00K	USD	2 Qtrs
Realized (gain) loss on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-98.00K	USD	2 Qtrs
Unrealized loss (gain) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-614.00K	USD	2 Qtrs
Unrealized loss (gain) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$138.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-76.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-82.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$100.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$608.00K	USD	2 Qtrs
Accrued salaries and benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-389.00K	USD	2 Qtrs
Accrued salaries and benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-127.00K	USD	2 Qtrs
Payable to DatChat	`IncreaseDecreaseInPayableToDatchat`	$207.00K	USD	2 Qtrs
Payable to DatChat	`IncreaseDecreaseInPayableToDatchat`	$-50.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.39M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.61M	USD	2 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$4.95M	USD	2 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$78.04M	USD	2 Qtrs
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$6.88M	USD	2 Qtrs
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$52.22M	USD	2 Qtrs
Sale of Hoth common shares	`ProceedsFromSaleOfCommonStock`	-	USD	2 Qtrs
Sale of Hoth common shares	`ProceedsFromSaleOfCommonStock`	$460.00K	USD	2 Qtrs
Purchase of investments at fair value	`PaymentsToAcquiresInvestment`	-	USD	2 Qtrs
Purchase of investments at fair value	`PaymentsToAcquiresInvestment`	$550.00K	USD	2 Qtrs
Purchase of research and development licenses	`PaymentsToAcquireInProcessResearchAndDevelopment`	$1.11M	USD	2 Qtrs
Purchase of research and development licenses	`PaymentsToAcquireInProcessResearchAndDevelopment`	-	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-26.48M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.37M	USD	2 Qtrs
Proceeds from issuance common stock, common warrants and prefunded warrants, net of offering	`ProceedsFromIssuanceCommonStockCommonWarrantsAndPrefundedWarrantsNetOfOfferingCost`	-	USD	2 Qtrs
Proceeds from issuance common stock, common warrants and prefunded warrants, net of offering	`ProceedsFromIssuanceCommonStockCommonWarrantsAndPrefundedWarrantsNetOfOfferingCost`	$6.56M	USD	2 Qtrs
Proceeds from issuance common stock, net of offering cost	`ProceedsFromIssuanceOfCommonStock`	$17.84M	USD	2 Qtrs
Proceeds from issuance common stock, net of offering cost	`ProceedsFromIssuanceOfCommonStock`	$787.00K	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$7.20M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$31.61M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$787.00K	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$2.74M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$547.00K	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$564.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.83M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$17.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$564.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.83M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$17.00K	USD	Point-in-time

Stockholders Equity 31 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$20.98M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.53M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.21M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.96M	USD	Point-in-time
Balance	`StockholdersEquity`	$12.10M	USD	Point-in-time
Balance	`StockholdersEquity`	$31.49M	USD	Point-in-time
Issuance of common stock and prefunded common stock warrants, net of offering cost	`StockIssuedDuringPeriodValueNewIssues2`	$6.56M	USD	2 Qtrs
Issuance of common stock and prefunded common stock warrants, net of offering cost	`StockIssuedDuringPeriodValueNewIssues2`	$787.00K	USD	2 Qtrs
Issuance of common stock and prefunded common stock warrants, net of offering cost	`StockIssuedDuringPeriodValueNewIssues2`	$787.00K	USD	1 Quarter
Exercise of prefunded common stock warrants	`SrtockIssuedDuringPeriodValueIssuedExerciseOfPrefundedCommonStockWarrants`	-	USD	1 Quarter
Exercise of prefunded common stock warrants	`SrtockIssuedDuringPeriodValueIssuedExerciseOfPrefundedCommonStockWarrants`	-	USD	2 Qtrs
Exchange of common shares for prefunded warrants	`StockIssuedDuringPeriodValueExchangeOfCommonSharesForPrefundedWarrants`	-	USD	2 Qtrs
Exchange of common shares for prefunded warrants	`StockIssuedDuringPeriodValueExchangeOfCommonSharesForPrefundedWarrants`	-	USD	1 Quarter
Fractional shares adjusted for reverse split	`AdjustmentsToAdditionalPaidInCapitalStockSplit`	-	USD	2 Qtrs
Fractional shares adjusted for reverse split	`AdjustmentsToAdditionalPaidInCapitalStockSplit`	-	USD	1 Quarter
Issuance of common stock, net of offering cost	`StockIssuedDuringPeriodValueNewIssues`	$12.77M	USD	1 Quarter
Issuance of common stock, net of offering cost	`StockIssuedDuringPeriodValueNewIssues`	$17.84M	USD	2 Qtrs
Common warrant and prefunded warrant exercise	`StockIssuedDuringPeriodValueOfCommonWarrantAndPrefundedWarrantExercise`	$7.20M	USD	2 Qtrs
Common warrant and prefunded warrant exercise	`StockIssuedDuringPeriodValueOfCommonWarrantAndPrefundedWarrantExercise`	$65.00K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$115.00K	USD	2 Qtrs
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$109.00K	USD	1 Quarter
Net Income (loss)	`NetIncomeLoss`	$-10.65M	USD	2 Qtrs
Net Income (loss)	`NetIncomeLoss`	$-644.00K	USD	1 Quarter
Net Income (loss)	`NetIncomeLoss`	$-2.31M	USD	1 Quarter
Net Income (loss)	`NetIncomeLoss`	$-1.79M	USD	2 Qtrs
Balance	`StockholdersEquity`	$20.98M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.53M	USD	Point-in-time
Balance	`StockholdersEquity`	$11.21M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.96M	USD	Point-in-time
Balance	`StockholdersEquity`	$12.10M	USD	Point-in-time
Balance	`StockholdersEquity`	$31.49M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.